{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidwrylbxi35ew4rtnzwqzu42mik5wd65dgwvv2qo2hzzjaq4t227y",
    "uri": "at://did:plc:svcthvzunxmjidtlw23zva6n/app.bsky.feed.post/3mgx67lnhttn2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiaekrs43c7hfnsqcuymp2ti2ebremm6fnblqvnxrap5i6gjicasdy"
    },
    "mimeType": "image/jpeg",
    "size": 12725
  },
  "path": "/2026/03/13/biodlink-named-emerging-cdmo-of-the-year-at-the-2026-asia-pacific-biopharma-excellence-awards/",
  "publishedAt": "2026-03-13T13:00:00.000Z",
  "site": "https://laotiantimes.com",
  "tags": [
    "Cision PR Newswire"
  ],
  "textContent": "BioDlink has been named “Emerging CDMO of the Year” for its innovation in complex biologics and ADC development. The award recognizes its proprietary technology platforms, scalable manufacturing, and a proven quality system with over 100 audits completed. SUZHOU, China, March 13, 2026 /PRNewswire/ — BioDlink, an innovation-driven Contract Development and Manufacturing Organization (CDMO), today announced […]",
  "title": "BioDlink Named “Emerging CDMO of the Year” at the 2026 Asia-Pacific Biopharma Excellence Awards"
}